Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-25 Sale | 2024-03-26 6:09 pm | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. HEAD OF R&D | 10,000 | $16.01 | $160,055 | 2,184,662 (Indirect Direct) | View |
| 2024-03-11 Sale | 2024-03-13 4:24 pm | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. HEAD OF R&D | 30,000 | $15.24 | $457,314 | 2,194,662 (Indirect Direct) | View |
| 2024-02-27 Sale | 2024-02-28 7:55 pm | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. HEAD OF R&D | 20,000 | $16.11 | $322,166 | 2,224,662 (Indirect Direct) | View |
| 2024-02-16 Sale | 2024-02-20 6:48 pm | Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam GENERAL COUNSEL | 3,242 | $15.25 | $49,434 | 123,736 (Direct) | View |
| 2024-02-16 Sale | 2024-02-20 6:36 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO AND SECRETARY | 2,666 | $15.25 | $40,651 | 411,504 (Direct) | View |
| 2024-02-16 Sale | 2024-02-20 6:26 pm | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. HEAD OF RESEARCH AND DEVELOPME | 2,258 | $15.25 | $34,430 | 2,359,732 (Indirect Direct) | View |
| 2024-02-16 Sale | 2024-02-20 6:14 pm | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy CHIEF EXECUTIVE OFFICER | 7,615 | $15.25 | $116,114 | 2,018,042 (Indirect Direct) | View |
| 2023-11-16 Sale | 2023-11-17 6:33 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 956 | $11.69 | $11,176 | 308,170 (Direct) | View |
| 2023-11-16 Sale | 2023-11-17 6:30 pm | Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam General Counsel | 5,313 | $11.69 | $62,109 | 67,978 (Direct) | View |
| 2023-11-16 Sale | 2023-11-17 6:26 pm | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Head of Research and Developme | 709 | $11.69 | $8,288 | 2,264,990 (Indirect Direct) | View |
| 2023-11-16 Sale | 2023-11-17 6:20 pm | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer | 3,107 | $11.69 | $36,321 | 1,838,657 (Indirect Direct) | View |
| 2023-10-18 Purchase | 2023-10-20 4:02 pm | Day One Biopharmaceuticals Inc. | DAWN | AI Day1 LLC Access Industries Holdings LLC ACCESS INDUSTRIES MANAGEMENT LLC Blavatnik Len 10% Owner | 1,475,454 | $10.15 | $14,978,327 | 12,929,322 (Direct) | View |
| 2023-08-17 Sale | 2023-08-17 7:02 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 922 | $13.86 | $12,779 | 309,126 (Direct) | View |
| 2023-08-17 Sale | 2023-08-17 6:21 pm | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Head of Research and Developme | 668 | $13.86 | $9,258 | 2,265,699 (Indirect Direct) | View |
| 2023-08-17 Sale | 2023-08-17 6:16 pm | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer | 2,996 | $13.86 | $41,525 | 1,841,764 (Indirect Direct) | View |
| 2023-06-09 Purchase | 2023-06-12 4:03 pm | Day One Biopharmaceuticals Inc. | DAWN | AI Day1 LLC Access Industries Holdings LLC ACCESS INDUSTRIES MANAGEMENT LLC Blavatnik Len 10% Owner | 769,230 | $13 | $9,999,990 | 11,453,868 (Direct) | View |
| 2023-06-05 Sale | 2023-06-07 4:51 pm | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer | 1,229 | $16 | $19,664 | 2,234,363 (Indirect Direct) | View |
| 2023-05-16 Sale | 2023-05-17 6:36 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 955 | $13.12 | $12,532 | 310,048 (Direct) | View |
| 2023-05-16 Sale | 2023-05-17 6:31 pm | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer | 692 | $13.12 | $9,081 | 2,267,596 (Indirect Direct) | View |
| 2023-05-16 Sale | 2023-05-17 6:27 pm | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer | 3,104 | $13.12 | $40,732 | 1,844,760 (Indirect Direct) | View |
| 2023-03-10 Sale | 2023-03-14 6:19 pm | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer | 10,000 | $18.05 | $180,484 | 2,233,660 (Indirect Direct) | View |
| 2023-03-07 Sale | 2023-03-08 5:50 pm | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer | 12,500 | $20.01 | $250,114 | 1,737,424 (Indirect Direct) | View |
| 2023-03-01 Sale | 2023-03-03 5:48 pm | Day One Biopharmaceuticals Inc. | DAWN | Grant Julie Papanek Director | 25,000 | $18.61 | $465,303 | 2,880,761 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-15 Exercise | 2024-02-20 6:48 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam GENERAL COUNSEL | 8,399 | $0 | 123,736 (Direct) | View |
| 2024-02-15 Exercise | 2024-02-20 6:36 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO AND SECRETARY | 10,250 | $0 | 411,504 (Direct) | View |
| 2024-02-15 Exercise | 2024-02-20 6:26 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. HEAD OF RESEARCH AND DEVELOPME | 8,686 | $0 | 2,359,732 (Direct) | View |
| 2024-02-15 Exercise | 2024-02-20 6:14 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy CHIEF EXECUTIVE OFFICER | 19,999 | $0 | 2,018,042 (Direct) | View |
| 2024-01-17 Option Award | 2024-01-19 5:22 pm | N/A 2034-01-16 | Day One Biopharmaceuticals Inc. | DAWN | Grossman William Director | 66,660 | $0 | 66,660 (Direct) | View |
| 2024-01-17 Option Award | 2024-01-19 5:19 pm | N/A 2034-01-16 | Day One Biopharmaceuticals Inc. | DAWN | Dable Habib J Director | 66,660 | $0 | 66,660 (Direct) | View |
| 2024-01-05 Option Award | 2024-01-09 7:29 pm | N/A 2034-01-04 | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 268,000 | $0 | 268,000 (Direct) | View |
| 2024-01-05 Option Award | 2024-01-09 7:25 pm | N/A 2034-01-04 | Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam General Counsel | 149,000 | $0 | 149,000 (Direct) | View |
| 2024-01-05 Option Award | 2024-01-09 7:22 pm | N/A 2034-01-04 | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Head of Research and Developme | 245,000 | $0 | 245,000 (Direct) | View |
| 2024-01-05 Option Award | 2024-01-09 7:17 pm | N/A 2034-01-04 | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer | 473,000 | $0 | 473,000 (Direct) | View |
| 2023-11-15 Exercise | 2023-11-17 6:33 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 3,625 | $0 | 308,170 (Direct) | View |
| 2023-11-15 Exercise | 2023-11-17 6:30 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam General Counsel | 13,600 | $0 | 67,978 (Direct) | View |
| 2023-11-15 Exercise | 2023-11-17 6:26 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Head of Research and Developme | 2,624 | $0 | 2,264,990 (Direct) | View |
| 2023-11-15 Exercise | 2023-11-17 6:20 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer | 8,312 | $0 | 1,838,657 (Direct) | View |
Ownership | 2023-11-16 8:39 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam General Counsel | 0 | $0 | 472,291 (Direct) | View |
| 2023-08-15 Exercise | 2023-08-17 7:02 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 3,625 | $0 | 309,126 (Direct) | View |
| 2023-08-15 Exercise | 2023-08-17 6:21 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Head of Research and Developme | 2,624 | $0 | 2,265,699 (Direct) | View |
| 2023-08-15 Exercise | 2023-08-17 6:16 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer | 8,312 | $0 | 1,841,764 (Direct) | View |
| 2023-07-01 Gift | 2023-07-05 7:47 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer | 329,963 | $0 | 1,449,710 (Direct) | View |
| 2023-07-01 Other | 2023-07-05 7:47 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer | 240,288 | $0 | 1,449,710 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-26 7:47 pm | N/A 2033-06-21 | Day One Biopharmaceuticals Inc. | DAWN | Ramasastry Saira Director | 37,500 | $0 | 37,500 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-26 7:44 pm | N/A 2033-06-21 | Day One Biopharmaceuticals Inc. | DAWN | Nicholson Garry A Director | 37,500 | $0 | 37,500 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-26 7:39 pm | N/A 2033-06-21 | Day One Biopharmaceuticals Inc. | DAWN | Josey John A. Director | 37,500 | $0 | 37,500 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-26 7:35 pm | N/A 2033-06-21 | Day One Biopharmaceuticals Inc. | DAWN | Holles Natalie C. Director | 37,500 | $0 | 37,500 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-26 7:24 pm | N/A 2033-06-21 | Day One Biopharmaceuticals Inc. | DAWN | Gladstone Michael Director | 37,500 | $0 | 37,500 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-26 7:19 pm | N/A 2033-06-21 | Day One Biopharmaceuticals Inc. | DAWN | Garland J. Scott Director | 37,500 | $0 | 37,500 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-26 7:15 pm | N/A 2033-06-21 | Day One Biopharmaceuticals Inc. | DAWN | Becker Daniel J. Director | 37,500 | $0 | 37,500 (Direct) | View |
| 2023-05-15 Exercise | 2023-05-17 6:36 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary | 3,625 | $0 | 310,048 (Direct) | View |
| 2023-05-15 Exercise | 2023-05-17 6:31 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer | 2,624 | $0 | 2,267,596 (Direct) | View |
| 2023-05-15 Exercise | 2023-05-17 6:27 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer | 8,312 | $0 | 1,844,760 (Direct) | View |